Many patients on GLP‑1 therapy describe their cravings as quieter, their urges to snack reduced, and their minds less consumed by food. This shift, often described as a reduction in “food noise,” reflects significant physiological changes triggered by GLP‑1 medications. As more clinicians prescribe these therapies, it’s vital to understand …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.